Analyst Price Targets — AIRS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 14, 2026 10:04 am | — | Leerink Partners | $4.50 | $4.66 | TheFly | AirSculpt Technologies price target raised to $4.50 from $3 at Leerink |
| November 11, 2025 9:49 am | Whit Mayo | Leerink Partners | $6.00 | $6.34 | StreetInsider | Airsculpt Technologies Inc. (AIRS) PT Raised to $6 at Leerink Partners |
| May 14, 2024 6:26 am | Whit Mayo | Leerink Partners | $5.00 | $4.67 | TheFly | AirSculpt Technologies downgraded to Market Perform from Outperform at Leerink |
| November 11, 2022 3:07 pm | Korinne Wolfmeyer | Piper Sandler | $4.00 | $3.28 | TheFly | Piper downgrades AirSculpt to Neutral, slashes target to $4 on weak visibility |
| August 24, 2022 7:47 am | — | Morgan Stanley | $11.00 | $9.81 | Benzinga | Morgan Stanley Maintains Equal-Weight on AirSculpt Technologies, Raises Price Target to $11 |
Latest News for AIRS
HONG KONG & SEOUL, South Korea--(BUSINESS WIRE)--AIRS Medical (“the Company”), a global leader in AI solutions for medical imaging, today announced a strategic growth investment from TA Associates (“TA”), a leading global private equity firm. The investment will help fuel AIRS Medical's next phase of global expansion, advancement of its AI-powered radiology technology solutions and ongoing product innovation.…
Palo Alto Networks is seeing rapid adoption of Prisma AIRS, with customer growth and larger AI security deals boosting its revenue potential.
MIAMI BEACH, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced that the Company will participate in upcoming investor conferences.
AirSculpt Technologies NASDAQ: AIRS executives said the body contouring company has returned to same-store sales growth after more than two years of declines, while outlining plans to expand services tied to GLP-1 weight-loss drug side effects and eventually resume clinic growth across the U.S.
AirSculpt Technologies, Inc. (AIRS) Shareholder/Analyst Call Prepared Remarks Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AIRS.
U.S. House Trading
No House trades found for AIRS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.